GENPATH PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are ARTEMIS PHARMACEUTICALS GMBH, BRESAGEN LTD and CASEBIA THERAPEUTICS LTD LIABILITY PARTNERSHIP.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | Australia | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Measuring microorganism processes | |
#5 | Animal care | |
#6 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | O'Hagan Ronan C | 12 |
#2 | Kannan Karuppiah | 7 |
#3 | Heyer Joerg | 6 |
#4 | Rideout William | 4 |
#5 | Clark Steven C | 3 |
#6 | Etemad-Moghadam Bijan | 3 |
#7 | Bailey David | 3 |
#8 | Robinson Murray O | 3 |
#9 | Jacks Tyler | 3 |
#10 | Pavlova Anna | 2 |
Publication | Filing date | Title |
---|---|---|
WO2005063987A1 | Gp153: methods and compositions for treating cancer | |
WO2005021754A1 | Gp131: methods and compositions for treating cancer | |
WO2005021724A2 | Gp115: methods and compositions for treating cancer | |
WO2004058948A2 | In vivo methods for validating the role of a tumor maintenance gene | |
AU2003299732A1 | Vectors for inducible rna interference | |
AU2003298708A1 | GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER | |
WO2004043408A2 | Gpc15: methods and compositions for treating cancer |